Currently predicting for Thu, 4 Jun 2026

LLY Prediction Chart

LLY Predictions History

Latest community submissions for LLY.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 26, 2024 $729.33 +0.62% $733.51 V 99.43% 4
Mar 13, 2024 $763.78 +1.17% $757.84 V 99.22% 3
Mar 13, 2024 $760.47 +0.73% $757.84 V 99.65% 5
Mar 13, 2024 Bullish $757.84 V 1
Mar 8, 2024 $774.93 -0.67% $762.14 V 98.32% 1
Mar 8, 2024 $788.52 +1.07% $762.14 X 96.54% 0
Mar 8, 2024 $783.50 +0.48% $762.14 X 97.20% 0
Feb 15, 2024 $752.82 -0.59% $757.78 X 99.35% 3
Feb 15, 2024 $750.13 -0.95% $757.78 X 98.99% 1
Feb 15, 2024 Bullish $757.78 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LLY with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ELI LILLY AND COMPANY
Eli Lilly
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE